Today on DrugResearcher.com
 
Biogen Idec aiming for biologic Alzheimer's drug

Merck-Frosst pushing mass spectroscopy into overdrive

Award for preclinical services firm

Bayer pipeline in good shape as merger rumours build

Amgen's approach to selectivity predictions

 
   
Related Industry News
 
North American CROs continue emerging market moves

GSK, MSD move on Singapore schemes

Vivalis scores another cell culture technology

United Drug makes second EU packaging purchase

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Wednesday 22 August 2007 Forward to a colleague

Product Overview

PharmatestPre-Clinical Contract Research - Free Download

Pharmatest offers unique preclinical in vitro and in vivo drug efficacy testing services to pharmaceutical companies developing new drugs against osteoporosis, cancer or osteoarthritis. Our services can also be used for testing existing compounds for possible adverse effects on bone or secondary indication for bone-related diseases, as well as development of functional foods for bone health... Click Here


Access Full Stories



Biogen Idec aiming for biologic Alzheimer's drug
A team of scientists at Biogen Idec have unveiled preclinical data for a potential protein therapeutic to treat Alzheimer's, a disease normally only attacked using small molecules due to delivery issues... Read


Merck-Frosst pushing mass spectroscopy into overdrive
Merck-Frosst Canada is pushing the limits of mass spectroscopy (MS), hoping to speed it up enough to achieve true high-throughput screening of difficult drug targets... Read


Award for preclinical services firm
Domainex, a London- and Cambridge-based preclinical services firm has won an industry award for its bottleneck-breaking genomics technology... Read


Bayer pipeline in good shape as merger rumours build
Analysts believe Bayer's research and development pipeline is well equipped to deal with looming patent expiries but that didn't stop rumours of a Novartis buyout last week... Read


Amgen's approach to selectivity predictions
Amgen has outlined how it uses computer models to predict the selectivity of small molecule drugs... Read


All News Headlines for:
August | July | June

deltaDOTTechnical / White paper

deltaDOT label free analysis of biomolecules

Faster, higher quality results at a fraction of the cost of conventional approaches. Analyse & Quantify Antibodies, Proteins and Small molecules - with high resolution, sensitivity & reproducibility... Click Here
Related Industry News



North American CROs continue emerging market moves
Two North American contract research organisation (CROs) have this week announced acquisitive moves into emerging clinical trials markets, while a third firm has extended an Asian partnership, as the emerging market... Read


GSK, MSD move on Singapore schemes
GlaxoSmithKline (GSK) and Merck Sharp & Dohme (MSD) have made further moves in their plans to boost their presence in Singapore, a region growing in popularity for biopharmaceutical research and manufacture... Read


Vivalis scores another cell culture technology
French biopharmaceutical company Vivalis has added another cell culture technology to its stronghold as it moves to dominate the avian stem cell market... Read


United Drug makes second EU packaging purchase
United Drug has made its second European contract packaging purchase as the Irish services firm continues to pursue expansion across the continent... Read

Weekly Comment

No lack of innovation in pharma, says Wyeth

The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development. Read



BionasSponsored Message

Live cell-based assay with Bionas® 2500 analyzing system

Bionas® 2500 measures multiple metabolic parameters simultaneously like acidification, oxygen consumption and adhesion of living cells. Metabolic and cytotoxic effects can be visualized as changes of these parameters in dependence of test compounds... Click Here

Previous Headlines



Applied Biosystems expanding genotyping access
Through a new service partnership, Applied Biosystems is helping scientists study genetic variations - even if they can't access or afford the necessary lab equipment... Read


UK tightens Phase I guidelines
The Association of the British Pharmaceutical Industry (ABPI) has now published revised guidelines for Phase I trials in the UK... Read


Amgen admits job cuts on way after anaemia drugs drama
Amgen has finally put an end to weeks of rumours and speculations by admitting its plans to slash 12-14 per cent of its workforce to offset the recent difficulties it has been facing with the sales of its anaemia... Read


Blockbuster potential for Actelion insomnia drug
Analysts are waiting with baited breath for the latest clinical data on Actelion's first-in-class insomnia drug, pointing to its blockbuster potential and deriding current insomnia drugs as 'shockingly limited'... Read


Did Pfizer overpay in Icagen deal?
Pfizer has penned a discovery-stage deal with Icagen aimed at finding potential pain alleviating drugs, but has forked out over twice the industry average... Read

Technical / White Papers, Case studies, Web casts
deltaDOT label free analysis of biomolecules - Technical / White paper



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com